Health Minister Rona Ambrose recently introduced Bill C-17, An Act to Amend the Food and Drugs Act. The bill reflects the government's promise to ensure that drug labels be written in plain language, and that the potential side effects of medication are accurately indicated. The bill also gives the government authority to require healthcare institutions to report adverse reactions.
Health Canada has announced its position on certain activities associated with unapproved medical devices and the corresponding roles and responsibilities of stakeholders and industry. Specifically, Health Canada now advises that unlicensed medical devices can be included in a request for proposal or information – a shift from its prior position that only licensed products could be the subject of such a request.